Personalis Inc
NASDAQ:PSNL

Watchlist Manager
Personalis Inc Logo
Personalis Inc
NASDAQ:PSNL
Watchlist
Price: 6.09 USD 2.35% Market Closed
Market Cap: 430.3m USD
Have any thoughts about
Personalis Inc?
Write Note

Relative Value

The Relative Value of one PSNL stock under the Base Case scenario is 1.97 USD. Compared to the current market price of 6.09 USD, Personalis Inc is Overvalued by 68%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PSNL Relative Value
Base Case
1.97 USD
Overvaluation 68%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
55
vs Industry
64
Median 3Y
1.9
Median 5Y
4
Industry
4.1
Forward
5.1
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-3.9
Industry
32.7
Forward
-4.1
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-6.5
Industry
22.1
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-5.7
Industry
33.6
vs History
55
vs Industry
64
Median 3Y
0.6
Median 5Y
1.7
Industry
2.6
vs History
55
vs Industry
75
Median 3Y
-0.4
Median 5Y
2
Industry
3.9
Forward
3.4
vs History
55
vs Industry
58
Median 3Y
-1.5
Median 5Y
5.6
Industry
8.6
vs History
vs Industry
53
Median 3Y
0.3
Median 5Y
-2.9
Industry
18.5
Forward
-4
vs History
vs Industry
47
Median 3Y
0.3
Median 5Y
-2.6
Industry
23.7
Forward
-4
vs History
vs Industry
56
Median 3Y
0.5
Median 5Y
-3.3
Industry
21.4
vs History
vs Industry
42
Median 3Y
0.4
Median 5Y
-3
Industry
28.8
vs History
55
vs Industry
62
Median 3Y
-0.3
Median 5Y
2.3
Industry
2.4

Multiples Across Competitors

PSNL Competitors Multiples
Personalis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Personalis Inc
NASDAQ:PSNL
430.2m USD 4.9 -4.7 -4.9 -4.1
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
164.6B CNY 4.3 20.4 14.8 14.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Personalis Inc
NASDAQ:PSNL
Average EV/EBITDA: 177.5
Negative Multiple: -4.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 538.7
23%
67.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.4
19%
1.1
US
Danaher Corp
NYSE:DHR
26.9
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.3
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.4
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.2
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.3
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.4
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
52%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Personalis Inc
NASDAQ:PSNL
Average EV/EBIT: 357.5
Negative Multiple: -4.1
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 279.1
130%
25.3
US
Thermo Fisher Scientific Inc
NYSE:TMO
30.6
57%
0.5
US
Danaher Corp
NYSE:DHR
40.4
59%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
49.4
76%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
37%
1.2
US
Agilent Technologies Inc
NYSE:A
26.1
42%
0.6
US
IQVIA Holdings Inc
NYSE:IQV
21.7
70%
0.3
US
Mettler-Toledo International Inc
NYSE:MTD
27.2
22%
1.3
US
West Pharmaceutical Services Inc
NYSE:WST
40.7
13%
3.2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
23%
0.6

See Also

Discover More
Back to Top